405 related articles for article (PubMed ID: 29278009)
1. Beneficial use of serum ferritin and heme oxygenase-1 as biomarkers in adult-onset Still's disease: A multicenter retrospective study.
Kirino Y; Kawaguchi Y; Tada Y; Tsukamoto H; Ota T; Iwamoto M; Takahashi H; Nagasawa K; Takei S; Horiuchi T; Ichida H; Minota S; Ueda A; Ohta A; Ishigatsubo Y
Mod Rheumatol; 2018 Sep; 28(5):858-864. PubMed ID: 29278009
[TBL] [Abstract][Full Text] [Related]
2. Increased serum HO-1 in hemophagocytic syndrome and adult-onset Still's disease: use in the differential diagnosis of hyperferritinemia.
Kirino Y; Takeno M; Iwasaki M; Ueda A; Ohno S; Shirai A; Kanamori H; Tanaka K; Ishigatsubo Y
Arthritis Res Ther; 2005; 7(3):R616-24. PubMed ID: 15899048
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of ferritin and glycosylated ferritin in adult onset Still's disease.
Fautrel B; Le Moël G; Saint-Marcoux B; Taupin P; Vignes S; Rozenberg S; Koeger AC; Meyer O; Guillevin L; Piette JC; Bourgeois P
J Rheumatol; 2001 Feb; 28(2):322-9. PubMed ID: 11246670
[TBL] [Abstract][Full Text] [Related]
4. Serum calprotectin--a promising diagnostic marker for adult-onset Still's disease.
Guo Q; Zha X; Li C; Jia Y; Zhu L; Guo J; Su Y
Clin Rheumatol; 2016 Jan; 35(1):73-9. PubMed ID: 26547221
[TBL] [Abstract][Full Text] [Related]
5. Serum leucine-rich α2-glycoprotein is a useful biomarker for monitoring disease activity in patients with adult-onset Still's disease.
Ha YJ; Kang EJ; Lee SW; Park YB; Lee SK; Song JS; Choi ST
Scand J Rheumatol; 2015; 44(5):399-403. PubMed ID: 26079682
[TBL] [Abstract][Full Text] [Related]
6. Percentage of glycosylated serum ferritin remains low throughout the course of adult onset Still's disease.
Vignes S; Le Moël G; Fautrel B; Wechsler B; Godeau P; Piette JC
Ann Rheum Dis; 2000 May; 59(5):347-50. PubMed ID: 10784516
[TBL] [Abstract][Full Text] [Related]
7. Extremely High Serum Ferritin: An Instrumental Marker of Masquerading Adult-Onset Still's Disease with Hemophagocytic Syndrome.
Yamashita S; Furukawa NE; Matsunaga T; Hirakawa Y; Tago M; Yamashita SI
Am J Case Rep; 2017 Dec; 18():1296-1301. PubMed ID: 29208852
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of Interleukin-18 as a Diagnostic Biomarker to Differentiate Adult-Onset Still's Disease With/Without Macrophage Activation Syndrome From Other Secondary Hemophagocytic Lymphohistiocytosis in Adults.
Shiga T; Nozaki Y; Tomita D; Kishimoto K; Hirooka Y; Kinoshita K; Funauchi M; Matsumura I
Front Immunol; 2021; 12():750114. PubMed ID: 34691064
[TBL] [Abstract][Full Text] [Related]
9. sCD163 in AOSD: a biomarker for macrophage activation related to hyperferritinemia.
Colafrancesco S; Priori R; Alessandri C; Astorri E; Perricone C; Blank M; Agmon-Levin N; Shoenfeld Y; Valesini G
Immunol Res; 2014 Dec; 60(2-3):177-83. PubMed ID: 25388964
[TBL] [Abstract][Full Text] [Related]
10. Biomarker screening and validation for the differentiation of bloodstream infection from adult-onset Still's disease: A prospective cohort study.
Zhang W; Yang T; Zhang H; Xu Y; Yang Q; Liu Q; Gao Y; Wu J; Shao L; Zhang W
Cytokine; 2021 Oct; 146():155642. PubMed ID: 34325118
[TBL] [Abstract][Full Text] [Related]
11. Ferritin and C-reactive protein are predictive biomarkers of mortality and macrophage activation syndrome in adult onset Still's disease. Analysis of the multicentre Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort.
Di Benedetto P; Cipriani P; Iacono D; Pantano I; Caso F; Emmi G; Grembiale RD; Cantatore FP; Atzeni F; Perosa F; Scarpa R; Guggino G; Ciccia F; Giacomelli R; Ruscitti P
PLoS One; 2020; 15(7):e0235326. PubMed ID: 32645077
[TBL] [Abstract][Full Text] [Related]
12. Serum S100A12 may be a useful biomarker of disease activity in adult-onset Still's disease.
Bae CB; Suh CH; An JM; Jung JY; Jeon JY; Nam JY; Kim HA
J Rheumatol; 2014 Dec; 41(12):2403-8. PubMed ID: 25274901
[TBL] [Abstract][Full Text] [Related]
13. Serum S100A8/A9, but not follistatin-like protein 1 and interleukin 18, may be a useful biomarker of disease activity in adult-onset Still's disease.
Kim HA; An JM; Nam JY; Jeon JY; Suh CH
J Rheumatol; 2012 Jul; 39(7):1399-406. PubMed ID: 22660800
[TBL] [Abstract][Full Text] [Related]
14. Elevated high-mobility group B1 levels in active adult-onset Still's disease associated with systemic score and skin rash.
Jung JY; Suh CH; Sohn S; Nam JY; Kim HA
Clin Rheumatol; 2016 Aug; 35(8):1937-1942. PubMed ID: 27225247
[TBL] [Abstract][Full Text] [Related]
15. Plasma microRNA Profiles as a Potential Biomarker in Differentiating Adult-Onset Still's Disease From Sepsis.
Hu Q; Gong W; Gu J; Geng G; Li T; Tian R; Yang Z; Zhang H; Shao L; Liu T; Wan L; Jia J; Yang C; Shi Y; Shi H
Front Immunol; 2018; 9():3099. PubMed ID: 30687316
[TBL] [Abstract][Full Text] [Related]
16. Serum Heparin-Binding Protein as a Potential Biomarker to Distinguish Adult-Onset Still's Disease From Sepsis.
Tian R; Chen X; Yang C; Teng J; Qu H; Liu HL
Front Immunol; 2021; 12():654811. PubMed ID: 33868298
[TBL] [Abstract][Full Text] [Related]
17. Serum sTREM-1 in adult-onset Still's disease: a novel biomarker of disease activity and a potential predictor of the chronic course.
Wang Z; Chi H; Sun Y; Teng J; Feng T; Liu H; Cheng X; Ye J; Shi H; Hu Q; Jia J; Liu T; Wan L; Zhou Z; Qiao X; Yang C; Su Y
Rheumatology (Oxford); 2020 Nov; 59(11):3293-3302. PubMed ID: 32276274
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 18: a biomarker for differential diagnosis between adult-onset Still's disease and sepsis.
Priori R; Colafrancesco S; Alessandri C; Minniti A; Perricone C; Iaiani G; Palazzo D; Valesini G
J Rheumatol; 2014 Jun; 41(6):1118-23. PubMed ID: 24786926
[TBL] [Abstract][Full Text] [Related]
19. Iron saturation of serum ferritin in patients with adult onset Still's disease.
ten Kate J; Drenth JP; Kahn MF; van Deursen C
J Rheumatol; 2001 Oct; 28(10):2213-5. PubMed ID: 11669158
[TBL] [Abstract][Full Text] [Related]
20. Hyperferritinemia in adult onset Still's disease and the hemophagocytic syndrome.
Coffernils M; Soupart A; Pradier O; Feremans W; Nève P; Decaux G
J Rheumatol; 1992 Sep; 19(9):1425-7. PubMed ID: 1433011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
